Bionas GmbH, a specialist for in vitro profiling of cellular metabolic activity, is pleased to announce that Dr. Carsten Haber will be joining its team as technical sales representative for the Bionas® 1500 and 2500 analyzing systems in the United States. Dr. Haber is an expert on analytical instrumentation and assay methods and worked for over nine years in R&D at Thermo Electron in Massachusetts (USA).
In addition to serving current clients and attracting new ones, Dr. Haber will focus on client problems and needs and show how they could be solved or mitigated with Bionas products or services. Dr. Haber will team up with Dr. Michael Schulze, who has been appointed Managing Director, a position he will hold jointly with Dr. Ralf Ehret, founder of Bionas GmbH.
The Bionas® 2500 analyzing system, the company’s leading product, allows the simultaneous, label-free and high-content analysis of three metabolic parameters, such as acidification, oxygen consumption and adhesion of living cells. It gives a complete overview of the physiological state of cells and can be used to analyze different signal transduction pathways, allowing target validation studies at an early stage in the drug discovery process.
In addition to serving current clients and attracting new ones, Dr. Haber will focus on client problems and needs and show how they could be solved or mitigated with Bionas products or services. Dr. Haber will team up with Dr. Michael Schulze, who has been appointed Managing Director, a position he will hold jointly with Dr. Ralf Ehret, founder of Bionas GmbH.
The Bionas® 2500 analyzing system, the company’s leading product, allows the simultaneous, label-free and high-content analysis of three metabolic parameters, such as acidification, oxygen consumption and adhesion of living cells. It gives a complete overview of the physiological state of cells and can be used to analyze different signal transduction pathways, allowing target validation studies at an early stage in the drug discovery process.
